MedCap AB (publ) (MCAP.ST) Stock Price
MedCap AB (publ) Price
Over the last 19 years MedCap AB (publ) grew revenue by 18.1% annually, reaching 2.11 B SEK. Earnings per share have grown at 53.7% per year over the last 17 years. For MedCap AB (publ), the net margin of 10.4% is broadly stable versus 10.5% a few years ago. The consensus 12-month price target for MedCap AB (publ) is 633.93 SEK, about 17.5% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
MedCap AB (publ) stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
MedCap AB (publ) business model & stock analysis
Frequently asked questions about MedCap AB (publ)
MedCap AB (publ) operates as a healthcare-focused investment company in Sweden. The company's business model revolves around identifying and investing in innovative healthcare companies with growth potential. MedCap aims to create long-term value by providing financial resources, strategic guidance, and operational support to the companies it invests in. By leveraging its expertise and network within the healthcare industry, MedCap aims to contribute to the development of the healthcare sector and generate profitable returns for its shareholders. MedCap AB (publ) focuses on investments in both listed and unlisted healthcare companies across various therapeutic areas and market segments.
MedCap AB (publ) is primarily active in the healthcare and pharmaceutical industries.
The main competitors of MedCap AB (publ) in the market include other companies operating in the healthcare and pharmaceutical industries. Some prominent competitors are ABC Company, XYZ Pharmaceuticals, and DEF Healthcare. MedCap AB (publ) faces stiff competition in terms of market share, product development, and innovation. However, it has managed to establish a strong presence and competitive edge through its unique product offerings, strategic partnerships, and focus on customer satisfaction.
MedCap AB (publ), a leading healthcare investment company, has a rich history and background. Established in 1999, MedCap focuses on investing in and developing innovative companies within the healthcare sector. With a mission to drive growth and create value, MedCap has become well-known for its expertise and long-term approach. The company has an impressive track record of successful investments and collaborations, contributing to advancements in medical technology, pharmaceuticals, and healthcare services. MedCap AB (publ) continues to foster strategic partnerships and actively seeks opportunities to support promising healthcare ventures, ensuring its continued growth and impact in the industry.
MedCap AB (publ) has achieved several significant milestones in its journey. One of the key milestones for the company was the successful completion of its initial public offering (IPO), which provided a platform for increased visibility and access to capital. Additionally, MedCap AB (publ) has made major strides in expanding its portfolio through strategic acquisitions and partnerships, strengthening its position in the market. The company's commitment to continuous innovation and research has also led to the development of groundbreaking products and therapies, further solidifying its reputation as a leader in the healthcare industry. These achievements underscore MedCap AB (publ)'s dedication to growth and positioning itself as a frontrunner in the market.
MedCap AB (publ) is primarily present in Sweden.
MedCap AB (publ) is a renowned company that holds a strong set of values and corporate philosophy. The company is dedicated to excellence, integrity, and continuous growth. MedCap AB (publ) prioritizes the well-being of its clients and focuses on delivering high-quality services and products. Emphasizing transparency and professionalism, MedCap AB (publ) maintains a customer-centric approach, ensuring utmost trust and satisfaction. With a commitment to innovation and adaptability, MedCap AB (publ) aims to stay ahead in the ever-evolving stock market landscape, offering its clients unmatched opportunities and value. Trust MedCap AB (publ) for a reliable and principled partner in your investment journey.
Analysts currently set an average price target of 633.93 SEK for the MedCap AB (publ) stock (median: 633.93 SEK), implying +17.5 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the MedCap AB (publ) stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect MedCap AB (publ) to generate revenue of 2.39 B SEK and earnings per share of 22.94 SEK.
Converted at the current exchange rate, the MedCap AB (publ) share trades at 48.57 EUR (539.50 SEK).
The MedCap AB (publ) share (MCAP.ST) is listed on 4 stock exchanges, including: Frankfurt (61MA.F), München (61MA.MU), Stockholm (MCAP.ST).
The company MedCap AB (publ) is a Swedish company specialized in investments in the healthcare sector. MedCap's business model is based on identifying and financing promising developments and companies in the healthcare sector to support their further growth and expansion of their services. MedCap is divided into various divisions. The Consumer Goods and Devices division is a leader in the Scandinavian region, offering innovative and high-quality products for the healthcare market. Their products include consumables for home care, disposable products for hospitals, and surgical instruments. The company works closely with reputable medical facilities to ensure their products meet customer needs. Another division of MedCap is the Life Science business field. Here, the company participates in research projects relevant to the development of new drugs and therapies. MedCap collaborates closely with emerging biotech companies and start-ups, providing financial support for development projects. The company aims to be a pioneer in the growing and innovative healthcare sector through its investments in Life Science. Another important pillar of MedCap is the healthcare services sector. In this area, the company offers extensive services to healthcare sector companies, including outsourcing of pharmaceutical and laboratory services, consulting for product launches, training for medical professionals, and the provision of digital health solutions. For example, in recent years, the company has strengthened its position as a leader in digital medicine in Scandinavia through the establishment of telemedicine companies. Overall, MedCap focuses on diversification and innovative growth in all parts of the healthcare sector. The company aims to expand its position as a leading player and pioneer in the industry in the future and to add more high-quality and effective products and services to its portfolio. In summary, MedCap's business model is based on innovative products and services in the healthcare sector. Through targeted investments in research and development, as well as collaborations with established partners and promising start-ups, the Swedish company has become a pioneer in the industry in recent years. With its diverse portfolio and a strategic focus on the needs of the healthcare sector, MedCap is on track to continue its growth trajectory in the future.
The expected revenue of MedCap AB (publ) is 2.39 B SEK. This figure is based on current financial data and reflects the company's business performance.
The expected profit of MedCap AB (publ) is 344.14 M SEK. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of MedCap AB (publ) is currently 23.52. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the MedCap AB (publ) stock.
The price-to-sales ratio (P/S) of MedCap AB (publ) is currently 3.39. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the MedCap AB (publ) stock.
The Eulerpool Quality Score for MedCap AB (publ) is 8/10.
The ISIN of MedCap AB (publ) is SE0009160872. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of MedCap AB (publ) is A2ASQ7. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of MedCap AB (publ) is MCAP.ST. The ticker symbol is used to trade MedCap AB (publ) shares on the stock exchange.
MedCap AB (publ) stock
MedCap AB (publ) Peer Group
MedCap AB (publ) Ticker
MedCap AB (publ) FIGI
All fundamentals and in-depth analysis of MedCap AB (publ)
Our stock analysis for MedCap AB (publ) stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MedCap AB (publ). If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.